Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry.
about
Imaging mass spectrometry in neuroscience.Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP StudyMass spectrometry imaging, an emerging technology in neuropsychopharmacology.MALDI imaging of lipid biochemistry in tissues by mass spectrometry.Visualization of acetylcholine distribution in central nervous system tissue sections by tandem imaging mass spectrometryLipid imaging by mass spectrometry - a review.A spiked tissue-based approach for quantification of phosphatidylcholines in brain section by MALDI mass spectrometry imaging.DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery.Decreased level of phosphatidylcholine (16:0/20:4) in multiple myeloma cells compared to plasma cells: a single-cell MALDI-IMS approach.MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.Direct profiling of the phospholipid composition of adult Caenorhabditis elegans using whole-body imaging mass spectrometry.Development of an Imaging Mass Spectrometry Technique for Visualizing Localized Cellular Signaling Mediators in Tissues.MALDI mass spectrometry imaging: A cutting-edge tool for fundamental and clinical histopathology.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.Decreased 16:0/20:4-phosphatidylinositol level in the post-mortem prefrontal cortex of elderly patients with schizophrenia.Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Mass spectrometry coupled to imaging techniques: the better the view the greater the challenge.Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury.Molecular composition of the human primary visual cortex profiled by multimodal mass spectrometry imaging.
P2860
Q27024594-0C9DA87A-0F99-4BB4-9F1C-00E52A753547Q27329481-CC52660C-64A8-475B-AC8A-D1B855E4F452Q30422058-D3628E9E-AD4F-4BBF-839A-504CB7B13B4BQ34028743-D56E3667-721F-4944-8702-DBA26D7C2C5AQ34242700-89AB2C4A-57DC-4D60-898C-2830E56BEF65Q34546576-F9587478-75A9-4B06-AB67-9B62DD428920Q35345555-BE166FE3-06B4-48B7-B286-A89EEA245150Q35438097-9FBAA1CF-40B5-447A-89FB-3569D4FE3404Q35460424-4D01A6A5-6D8A-4CBF-8644-0FD6B8A52D56Q35626025-EE4D4C36-9FF2-4271-A143-E5865AEC96CCQ35687880-4764A5B5-E8D0-4A31-99A3-093AF7736C20Q35756667-9404E074-6326-4753-9C2E-D02C31CB5CBFQ35969085-7BEE99B3-BEDA-4916-8FFC-4B493C8FCA62Q36020378-24B0DA33-85B9-41A2-B6F8-593CD67BB130Q36052708-8D089D21-24DF-4555-B8E9-7F39CEAE1630Q36379339-1F82A4D8-C4DA-4E5E-811D-FE540D0242BAQ36750552-36338CA8-AEAD-4DFD-8E2A-2A769F9B5901Q37717294-D393F675-A1BD-461C-A9C0-BCD16DF8C0B5Q38712870-252CA06D-8528-4F42-A3D9-154E758ECDEAQ40058836-9861FF70-37B8-46DE-B7E9-661496B8C061Q43115402-0C8077AD-233D-46AE-82E0-8DD27653E585Q48616515-C2315B64-7FD9-4053-869A-5F1E81FFFE27Q52597361-866B97ED-90D2-4AE8-A591-4D11DF6A5215
P2860
Abnormal phospholipids distribution in the prefrontal cortex from a patient with schizophrenia revealed by matrix-assisted laser desorption/ionization imaging mass spectrometry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@ast
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@en
type
label
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@ast
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@en
prefLabel
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@ast
Abnormal phospholipids distrib ...... ion imaging mass spectrometry.
@en
P2093
P2860
P921
P1476
Abnormal phospholipids distrib ...... tion imaging mass spectrometry
@en
P2093
Akira Hori
Akira Wada
Hiroyasu Akatsu
Keiko Ikemoto
Keisuke Nishiura
Mitsutoshi Setou
Naoko Goto-Inoue
Nobuhiro Zaima
Qiaohui Yang
P2860
P2888
P304
P356
10.1007/S00216-011-4909-3
P407
P577
2011-04-02T00:00:00Z